Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism (Q42031194)
Jump to navigation
Jump to search
scientific article published on 2 October 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism |
scientific article published on 2 October 2013 |
Statements
1 reference
Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism (English)
1 reference
Alan D Cherrington
1 reference
Mary Courtney Moore
1 reference
Marta S Smith
1 reference
Vikram P Sinha
1 reference
John M Beals
1 reference
M Dodson Michael
1 reference
Scott J Jacober
1 reference
2 October 2013
1 reference
1 reference
494-504
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference